Increased ADAMTS13 activity in patients with venous thromboembolism

Thrombosis Research

Volumn 130, Issue 6, 2012, Pages 889-893

  Mazetto, Bruna M ^a   Orsi, Fernanda L ^a   Barnabé, Aline ^a   De Paula, Érich V ^a   Flores Nascimento, Mariane C ^a   Annichino Bizzacchi, Joyce M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENCE RISK; RECURRENT DISEASE; RESIDUAL VEIN OBSTRUCTION; RETROSPECTIVE STUDY; VEIN OCCLUSION; VENOUS THROMBOEMBOLISM;

ADAM PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 84870239475     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.09.009     Document Type: Article

References (30)

1. F.R. Rosendaal Venous thrombosis: a multicausal disease Lancet 353 9159 Apr. 3 1999 1167 1173
2. E.M. Roumen-Klappe, M. den Heijer, S.H. van Uum, J. van der Ven-Jongekrijg, F. van der Graaf, and H. Wollersheim Inflammatory response in the acute phase of deep vein thrombosis J Vasc Surg 35 4 Apr. 2002 701 706
3. A. van Hylckama Vlieg, I.K. van der Linden, R.M. Bertina, and F.R. Rosendaal High levels of factor IX increase the risk of venous thrombosis Blood 95 12 Jun. 15 2000 3678 3682
4. A.W. Tsai, M. Cushman, W.D. Rosamond, S.R. Heckbert, R.P. Tracy, and N. Aleksic Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE) Am J Med 113 8 Dec. 1 2002 636 642
5. Mello T. Fibrinogênio, FVII, FVIII, FIX e FXI como fatores de risco para tromboembolismo venoso em pacientes de uma população brasileira [Doutorado]. Campinas: Universidade Estadual de Campinas; 2006.
6. B.E. van Aken, M. den Heijer, G.M. Bos, S.J. van Deventer, and P.H. Reitsma Recurrent venous thrombosis and markers of inflammation Thromb Haemost 83 4 Apr. 2000 536 539
7. T.B. Mello, L.H. Siqueira, S.A. Montavao, M.C. Ozello, and J.M. Annichino-Bizzacchi Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism Thromb Res 121 5 2008 625 629
8. P.W. Kamphuisen, J.C. Eikenboom, F.R. Rosendaal, T. Koster, A.D. Blann, and H.L. Vos High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene Br J Haematol 115 1 Oct. 2001 156 158
9. D.W. Chung, and K. Fujikawa Processing of von Willebrand factor by ADAMTS-13 Biochemistry 41 37 Sep. 17 2002 11065 11070
10. J.F. Dong Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions J Thromb Haemost 3 8 Aug. 2005 1710 1716
11. G.G. Levy, D.G. Motto, and D. Ginsburg ADAMTS13 turns 3 Blood 106 1 Jul. 1 2005 11 17
12. J.L. Moake von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura Semin Hematol 41 1 Jan. 2004 4 14
13. P.M. Mannucci, M.T. Canciani, I. Forza, F. Lussana, A. Lattuada, and E. Rossi Changes in health and disease of the metalloprotease that cleaves von Willebrand factor Blood 98 9 Nov. 1 2001 2730 2735
14. T.N. Bongers, M.P. de Maat, M.L. van Goor, V. Bhagwanbali, H.H. van Vliet, and E.B. Gomez Garcia High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability Stroke 37 11 Nov. 2006 2672 2677
15. T.N. Bongers, E.L. de Bruijne, D.W. Dippel, A.J. de Jong, J.W. Deckers, and D. Poldermans Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients Atherosclerosis 207 1 Nov. 2009 250 254
16. A. Bernardo, C. Ball, L. Nolasco, J.F. Moake, and J.F. Dong Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow Blood 104 1 Jul. 1 2004 100 106
17. M.A. Zago, and F.F. Costa Hereditary haemoglobin disorders in Brazil Trans R Soc Trop Med Hyg 79 3 1985 385 388
18. S.R. Kahn Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome J Thromb Haemost 7 5 May 2009 884 888
19. E.J. Favaloro, J. Smith, P. Petinos, M. Hertzberg, and J. Koutts Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel Thromb Haemost 82 4 Oct. 1999 1276 1282
20. S.G. Shelat, P. Smith, J. Ai, and X.L. Zheng Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo J Thromb Haemost 4 8 Aug. 2006 1707 1717
21. H.E. Gerritsen, P.L. Turecek, H.P. Schwarz, B. Lammle, and M. Furlan Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP) Thromb Haemost 82 5 Nov. 1999 1386 1389
22. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 14 Apr. 3 1997 973 979
23. B.E. van Aken, P.H. Reitsma, and F.R. Rosendaal Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis Br J Haematol 116 1 Jan. 2002 173 177
24. B.Q. Zhao, A.K. Chauhan, M. Canault, I.S. Patten, J.J. Yang, and M. Dockal von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke Blood 114 15 Oct. 8 2009 3329 3334
25. Rios DR, Fernandes AP, Figueiredo RC, Guimaraes DA, Ferreira CN, Simoes ESAC, et al. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis. J Thromb Thrombolysis May;33(4):416-421.
26. Kokame K, Sakata T, Kokubo Y, Miyata T. von Willebrand factor-to-ADAMTS13 ratio increases with age in a Japanese population. J Thromb Haemost Jul;9(7):1426-1428.
27. S. He, H. Cao, C.G. Magnusson, M. Eriksson-Berg, M. Mehrkash, and K. Schenck-Gustafsson Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein Thromb Res 103 3 Aug. 1 2001 241 248
28. P. Pottier, M. Fouassier, J.B. Hardouin, C. Volteau, and B. Planchon D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient Clin Appl Thromb Hemost 15 6 Dec. 2009 666 675
29. E.M. Roumen-Klappe, M.C. Janssen, J. Van Rossum, S. Holewijn, M.M. Van Bokhoven, and K. Kaasjager Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study J Thromb Haemost 7 4 Apr. 2009 582 587
30. H. Shbaklo, C.A. Holcroft, and S.R. Kahn Levels of inflammatory markers and the development of the post-thrombotic syndrome Thromb Haemost 101 3 Mar. 2009 505 512